Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2Br.Pb |
Molecular Weight | 367.0 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Br-].[Br-].[PbH2++]
InChI
InChIKey=NTZJGMFDNHZQIJ-UHFFFAOYSA-L
InChI=1S/2BrH.Pb.2H/h2*1H;;;/q;;+2;;/p-2
Molecular Formula | Pb |
Molecular Weight | 207.2 |
Charge | 2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | BrH |
Molecular Weight | 80.912 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/27486358http://nj.gov/health/eoh/rtkweb/documents/fs/1107.pdfhttps://www.ncbi.nlm.nih.gov/pubmed/2535340FRITZ BISCHOFF, L. C. MAXWELL, RICHARD D. EVANS, and FRANKLIN R. NUZUM. Journal of Pharmacology and Experimental Therapeutics September 1928, 34 (1) 85-109, retrived from http://jpet.aspetjournals.org/content/34/1/85 | https://www.ncbi.nlm.nih.gov/pubmed/14038324https://www.ncbi.nlm.nih.gov/pubmed/14038324https://www.ncbi.nlm.nih.gov/pubmed/20340530 | https://www.ncbi.nlm.nih.gov/pubmed/18935555Curator's Comment: description was created based on several sources, including
https://ntp.niehs.nih.gov/ntp/newhomeroc/roc11/lead-public_508.pdf
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27486358http://nj.gov/health/eoh/rtkweb/documents/fs/1107.pdfhttps://www.ncbi.nlm.nih.gov/pubmed/2535340FRITZ BISCHOFF, L. C. MAXWELL, RICHARD D. EVANS, and FRANKLIN R. NUZUM. Journal of Pharmacology and Experimental Therapeutics September 1928, 34 (1) 85-109, retrived from http://jpet.aspetjournals.org/content/34/1/85 | https://www.ncbi.nlm.nih.gov/pubmed/14038324https://www.ncbi.nlm.nih.gov/pubmed/14038324https://www.ncbi.nlm.nih.gov/pubmed/20340530 | https://www.ncbi.nlm.nih.gov/pubmed/18935555
Curator's Comment: description was created based on several sources, including
https://ntp.niehs.nih.gov/ntp/newhomeroc/roc11/lead-public_508.pdf
There is no information about biological application only a few articles about pharmacological application of lead fluoride, that this substance was investigated for topical dental caries.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Lead oxide emissions--a case history. | 1986 |
|
Maternal low-level lead exposure reduces the expression of PSA-NCAM and the activity of sialyltransferase in the hippocampi of neonatal rat pups. | 2008 Jul |
|
Probit analysis of comparative assays on toxicities of lead chloride and lead acetate to in vitro cultured human umbilical cord blood lymphocytes. | 2015 Mar |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27486358
It was investigated the cytotoxicity of lead chloride in vitro cultured lymphocytes from human umbilical cord blood, using four monitoring methods namely, trypan blue staining, acridine orange/ethidium bromide staining, 3-[4,5-dimethylthiazol-2-yl] 2,5-diphenyl tetrazolium bromide (MTT) and neutral red uptake assays; lead genotoxicity to lymphocytes was monitored by comet assay. The MIC value in each method was invariably 300 mg/L for PbCl2. Lethal concentration25 (LC25) values were almost in an agreeable range: 691.83 to 831.76 mg/L; LC50 values in each method were almost in the range: 1174.9 to 1348.9 mg/L; LC100 values were in the range: 3000 to 3300 mg/L, for lead chloride. The comet assay also indicated that the LC100 values were 3300 mg/L lead chloride. Thus, both cytotoxicity and genotoxicity were recorded at 3300 mg/L lead chloride with lymphocytes.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:45:21 GMT 2023
by
admin
on
Fri Dec 15 17:45:21 GMT 2023
|
Record UNII |
1O767M99U7
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
10031-22-8
Created by
admin on Fri Dec 15 17:45:21 GMT 2023 , Edited by admin on Fri Dec 15 17:45:21 GMT 2023
|
PRIMARY | |||
|
DTXSID701014306
Created by
admin on Fri Dec 15 17:45:21 GMT 2023 , Edited by admin on Fri Dec 15 17:45:21 GMT 2023
|
PRIMARY | |||
|
1O767M99U7
Created by
admin on Fri Dec 15 17:45:21 GMT 2023 , Edited by admin on Fri Dec 15 17:45:21 GMT 2023
|
PRIMARY | |||
|
LEAD(II) BROMIDE
Created by
admin on Fri Dec 15 17:45:21 GMT 2023 , Edited by admin on Fri Dec 15 17:45:21 GMT 2023
|
PRIMARY | |||
|
m6728
Created by
admin on Fri Dec 15 17:45:21 GMT 2023 , Edited by admin on Fri Dec 15 17:45:21 GMT 2023
|
PRIMARY | Merck Index | ||
|
C032721
Created by
admin on Fri Dec 15 17:45:21 GMT 2023 , Edited by admin on Fri Dec 15 17:45:21 GMT 2023
|
PRIMARY | |||
|
24831
Created by
admin on Fri Dec 15 17:45:21 GMT 2023 , Edited by admin on Fri Dec 15 17:45:21 GMT 2023
|
PRIMARY | |||
|
233-084-4
Created by
admin on Fri Dec 15 17:45:21 GMT 2023 , Edited by admin on Fri Dec 15 17:45:21 GMT 2023
|
PRIMARY |